Norman LevineGuidant CorpGDTDON'T BUYDec 05, 2005

Boston Scientific (BSX-N) is trying to buy. If you buy this stock, you are hoping that J&J (JNJ-N) will come with a higher bid which they might. This would be a trade rather than a long-term investment.

Norman Levine

Unlock Rating

$67.98

Stock price when the opinion was issued

biotechnologypharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

DON'T BUY

One of their large sectors is in stents, but they are not drug coated. Has a lot of competition.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Norman LevineGuidant CorpGDTDON'T BUYDec 05, 2005

You might be interested:

Guidant Corp(GDT)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals